The WTA Drew an Eligibility Line. Now Build a Process Athletes Can Trust.

A test is not the same thing as an eligibility system.

Once an institution decides to verify a category boundary, more questions immediately appear. Who orders the test? Which laboratories are trusted? Who sees the result? What is retained? What happens when a result is unusual? Who can review a decision? How does an athlete appeal?

And after eligibility has been established once, why should the athlete have to keep handing sensitive records to every organization that asks?

The competition system usually needs a very narrow answer: does this athlete satisfy the applicable eligibility rule?

Verification should prove the minimum necessary fact — not expose the maximum possible information.

Biology includes edge cases. The process has to know what to do with them.

World Athletics also uses SRY screening, but its regulations illustrate why the gene test cannot be treated as the entire policy. Its female-category rules include specific treatment for Complete Androgen Insensitivity Syndrome and transitional provisions for some athletes with differences of sex development.

That is important. A serious eligibility system cannot pretend uncommon cases do not exist simply because they are uncommon.

The rule, the evidence, the medical review and the appeal process have to work together.

DAO Sports is building the verification layer differently.

Our Zero-Knowledge Athlete Eligibility Protocol, or ZK-AEP, is designed around independent laboratories, medical eligibility review, privacy-preserving credentials, controlled retesting and dispute procedures.

The protocol does not decide who belongs in a division. It does not replace clinicians, laboratories, governing rules or due process. Its job is narrower: allow an authorized eligibility determination to become a credential that can be verified without handing the underlying medical record to the entire sports ecosystem.

The governance system should receive only the minimum necessary eligibility result. Sensitive evidence stays protected.

That is where blockchain and zero-knowledge technology become useful: not to determine biology, but to make a valid credential portable, tamper-evident and independently verifiable while revealing as little as possible.

There is an advantage to watching other institutions go first.

DAO Sports Association is still building. That means the WTA, World Athletics, the IOC and other governing bodies are generating real-world evidence before our system launches.

We can study where athletes experience confusion, where privacy protections work, where appeals are necessary, where laboratories create bottlenecks and where rules fail to anticipate an edge case. Then we can improve our own protocol before it is carrying the weight of a live controversy.

That is not hesitation. It is institutional learning.